четвъртък, 16 март 2023 г.

Weekly Digest: New diabetes clinical trial (14 items)


New diabetes clinical trial: Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes

Published on: February 21, 2022 at 07:00PM
Condition:   Type 2 Diabetes
Interventions:   Drug: CPL207280;   Drug: Placebo
Sponsors:   Celon Pharma SA;   National Center for Research and Development, Poland
Recruiting
https://clinicaltrials.gov/ct2/show/NCT05248776?term=diabetes&sfpd_d=14 February 21, 2022 at 03:22PM

via ClinicalTrials.gov


New diabetes clinical trial: "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."

Published on: February 22, 2022 at 07:00PM
Conditions:   Diabetes Mellitus, Type 2;   Weight Change, Body
Intervention:   Drug: Semaglutide Pen Injector
Sponsors:   Aga Khan University;   Rehman Medical Institute - RMI
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT05249881?term=diabetes&sfpd_d=14 February 22, 2022 at 02:23PM

via ClinicalTrials.gov


New diabetes clinical trial: The Evaluation of Laser Lancing Devices in Adult Type 2 Diabetes Patients

Published on: February 22, 2022 at 07:00PM
Condition:   Type 2 Diabetes
Intervention:   Device: laser lancing device or lancet for blood glucose level measurement
Sponsors:   Korea University Guro Hospital;   Korea Medical Device Development Fund
Recruiting
https://clinicaltrials.gov/ct2/show/NCT05251506?term=diabetes&sfpd_d=14 February 22, 2022 at 02:23PM

via ClinicalTrials.gov


New diabetes clinical trial: Altered Faecal Microbiome and Metabolome in CT1D, AT1D and T2D

Published on: February 23, 2022 at 07:00PM
Condition:   Type 1 Diabetes Mellitus Maturity Onset
Intervention:  
Sponsor:   Second Xiangya Hospital of Central South University
Recruiting
https://clinicaltrials.gov/ct2/show/NCT05252728?term=diabetes&sfpd_d=14 February 23, 2022 at 05:22PM

via ClinicalTrials.gov


New diabetes clinical trial: Effect of Education Based on The Health Belief Model on Healthy Lifestyle Behaviors in Individuals With Type 2 Diabetes

Published on: February 23, 2022 at 07:00PM
Condition:   Type 2 Diabetes
Intervention:   Behavioral: Education based on the health belief model
Sponsor:   Gazi University
Active, not recruiting
https://clinicaltrials.gov/ct2/show/NCT05252793?term=diabetes&sfpd_d=14 February 23, 2022 at 05:22PM

via ClinicalTrials.gov


New diabetes clinical trial: The Effect of Sensorial Biodex Balance Balance System Exercises in Diabetic Neuropathy

Published on: February 24, 2022 at 07:00PM
Conditions:   Diabetic Neuropathies;   Diabetes Mellitus;   Exercise Training
Intervention:   Device: Biodex Balance Exercise System
Sponsor:   Duygu AKTAR REYHANIOGLU
Completed
https://clinicaltrials.gov/ct2/show/NCT05255497?term=diabetes&sfpd_d=14 February 24, 2022 at 02:22PM

via ClinicalTrials.gov


New diabetes clinical trial: The Dietary Guidelines 3 Diet Patterns Study (DG3D): Phase 2

Published on: February 24, 2022 at 07:00PM
Conditions:   Diabetes Mellitus, Type 2;   Obesity
Intervention:   Behavioral: Dietary Intervention Classes
Sponsor:   University of South Carolina
Recruiting
https://clinicaltrials.gov/ct2/show/NCT05254496?term=diabetes&sfpd_d=14 February 24, 2022 at 02:22PM

via ClinicalTrials.gov


New diabetes clinical trial: A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease)...

Published on: February 24, 2022 at 07:00PM
Conditions:   Type 2 Diabetes Mellitus;   Chronic Kidney Disease
Interventions:   Drug: Finerenone (Kerendia, BAY94-8862 );   Drug: Empagliflozin;   Drug: Placebo
Sponsor:   Bayer
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT05254002?term=diabetes&sfpd_d=14 February 24, 2022 at 02:22PM

via ClinicalTrials.gov


New diabetes clinical trial: Safety and Efficacy of Human Microbiota Transplantation for Overweight and Obese Type 2 Diabetes Mellitus

Published on: February 24, 2022 at 07:00PM
Conditions:   Type 2 Diabetes Mellitus;   Overweight and Obesity
Interventions:   Biological: Fecal microbiota transplant (FMT);   Other: normal saline and glycerin/food coloring
Sponsors:   Zhujiang Hospital;   First Affiliated Hospital of Shantou University Medical College;   Dongguan People's Hospital;   Shenzhen Hengsheng Hospital;   The Fifth People's Hospital of Zhuhai;   Dongguan Wanjiang Hospital;   Shaoguan Qide Hospital;   People's Hospital of Wengyuan County, Shaoguan;   Zhaoqing First People's Hospital;   Suixi Hospital of Guangdong Medical University;   Shenzhen University General Hospital
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT05253768?term=diabetes&sfpd_d=14 February 24, 2022 at 02:22PM

via ClinicalTrials.gov


New diabetes clinical trial: Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)

Published on: February 25, 2022 at 07:00PM
Condition:   Type 1 Diabetes
Interventions:   Device: Hybrid closed-loop using ultra-rapid insulin lispro;   Device: Hybrid closed-loop using standard insulin lispro
Sponsor:   University of Cambridge
Recruiting
https://clinicaltrials.gov/ct2/show/NCT05257460?term=diabetes&sfpd_d=14 February 25, 2022 at 06:22PM

via ClinicalTrials.gov


New diabetes clinical trial: An Analysis to Assess Non-adherence in People With Type 2 Diabetes

Published on: February 25, 2022 at 07:00PM
Conditions:   Diabetes Mellitus, Type 2;   Hypertension;   Medication Adherence
Intervention:   Other: chemical adherence test, medication adherence questionnaire, pharmacy refill rate
Sponsor:   University of Leicester
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT05256875?term=diabetes&sfpd_d=14 February 25, 2022 at 06:22PM

via ClinicalTrials.gov


New diabetes clinical trial: SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes

Published on: February 25, 2022 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Diagnostic Test: SomaSignal Informed Medical Management SSCVD;   Other: Standard of Care
Sponsors:   Emory University;   SomaLogic, Inc.
Recruiting
https://clinicaltrials.gov/ct2/show/NCT05256706?term=diabetes&sfpd_d=14 February 25, 2022 at 06:22PM

via ClinicalTrials.gov


New diabetes clinical trial: Exercise Timing and Gestational Diabetes

Published on: February 25, 2022 at 07:00PM
Conditions:   Pregnancy Related;   Diabetes;   Diabete Mellitus;   Type 2 Diabetes;   Pre-diabetes;   Exercise
Interventions:   Behavioral: 30-minute walking intervention;   Behavioral: 10-minute
Sponsor:   University of Alberta
Recruiting
https://clinicaltrials.gov/ct2/show/NCT05256615?term=diabetes&sfpd_d=14 February 25, 2022 at 06:22PM

via ClinicalTrials.gov


New diabetes clinical trial: Investigation of Critically Ill Patients With Newly Diagnosed Diabetes

Published on: February 25, 2022 at 07:00PM
Condition:   Diabetes Mellitus
Intervention:   Diagnostic Test: Diabetes Diagnosis
Sponsor:   Stamford Hospital
Completed
https://clinicaltrials.gov/ct2/show/NCT05256043?term=diabetes&sfpd_d=14 February 25, 2022 at 06:22PM

via ClinicalTrials.gov


Няма коментари:

Публикуване на коментар